Discover the untapped potential of systems thinking in shaping effective policies and practices published in a new article.
Traditionally seen as too conceptual for policy relevance, systems thinking is now gaining traction in high-income countries, with governments embracing adaptive leadership and systemic evaluations.
But what about low- and middle-income countries? Resource constraints often hinder the institutionalization of systems thinking, making it challenging to replicate successful examples.
To overcome this, the study proposes three key steps:
1️⃣ Theorise and clarify the terminology of applied systems thinking in health policy and systems research (HPSR). By utilising systems modeling and other tools, we can better understand the interactions between interventions and their contexts.
2️⃣ Encourage greater government investment and institutional incentives to foster long-term collaboration and science-policy partnerships. This will enhance the capacities and practice of systems thinking in policymaking.
3️⃣ Advocate for funding norms that enable systems thinking in LMICs. Pooling resources and fostering networked institutions can address complexity and adaptive approaches, leading to more impactful outcomes.
To read the full article click on the link below.
📊 Are we truly capturing the full landscape of cancer care in South Africa?
A new patient-led cancer registry aims to transform data collection, empowering patients to report their diagnoses online. This initiative is set to fill critical gaps in current cancer statistics, enabling better resource allocation and improving cancer care policies.
Explore how patient involvement can reshape healthcare data in South Africa!
#SyenzaNews #HealthcareInnovation #HealthEconomics #resourceallocation
💡 Have you heard the latest on treatment options for rare kidney diseases?
Novartis’ Fabhalta (iptacopan) has received a positive opinion from the EMA, potentially paving the way for the first approved treatment for C3 glomerulopathy. This first-in-class therapy showed a remarkable 35.1% reduction in proteinuria, promising improved outcomes for patients facing this progressive condition.
Curious about the implications for healthcare and the economy? Dive into the full article to learn how Fabhalta could reshape the landscape for patients with C3G and other complement-mediated diseases.
#SyenzaNews #HealthcareInnovation #DrugDevelopment #MarketAccess
🔍 Could a new imaging agent revolutionize kidney cancer diagnosis?
The FDA’s acceptance of the Biologics License Application for TLX250-CDx marks a significant milestone in the fight against clear cell renal cell carcinoma (ccRCC). This investigational PET imaging tool promises non-invasive, high-accuracy diagnostics, which could lead to improved patient outcomes and better-targeted treatment plans.
Curious about its potential impact on healthcare and market dynamics? Dive into the full article to learn more!
#SyenzaNews #medicalimaging #oncology #HealthcareInnovation
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
